Example: Heart Attack

Clinical Trials on BRCA1 Hereditary Breast and Ovarian Cancer Syndrome

Total 14 results

NCT02978495

Recruiting

Neoadjuvant Carboplatin in Triple Negative Breast Cancer

Conditions: BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
NCT03162276

Unknown status

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Conditions: Hereditary Breast and Ovarian Cancer Syndrome
NCT01367639

Completed

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Conditions: Hereditary Breast and Ovarian Cancer Syndrome
NCT02653105

Recruiting

Women at Risk of Breast Cancer and OLFM4

Conditions: Hereditary Breast and Ovarian Cancer Syndrome
NCT02516540

Recruiting

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Conditions: Hereditary Breast and Ovarian Cancer
NCT02087592

Active, not recruiting

Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Conditions: Hereditary Breast and Ovarian Cancer
NCT01608074

Active, not recruiting

Radical Fimbriectomy for Young BRCA Mutation Carriers

Conditions: BRCA1 Mutation; BRCA2 Mutation; Hereditary Breast and Ovarian Cancer
NCT00535119

Completed

Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer

Conditions: Adult Solid Neoplasm; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Hereditary Breast and Ovarian Cancer Syndrome
NCT01333748

Completed

Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer

Conditions: Hereditary Breast and Ovarian Cancer Syndrome
NCT04668521

Recruiting

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

Conditions: Adnexal Mass; Germline BRCA1 Gene Mutation; Germline BRCA2 Gene Mutation; Hereditary Breast and Ovarian Cancer
NCT00892736

Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Conditions: Basal-Like Breast Carcinoma; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Breast Carcinoma; Estrogen Receptor Negative; HER2/Neu Negative; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Carcinoma; Pancreatic Carcinoma; Progesterone Receptor Negative; Prostate Carcinoma; Recurrent Breast Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Solid Neoplasm; Triple-Negative Breast Carcinoma
NCT03225170

Completed

Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling

Conditions: Breast Cancer
NCT02760849

Active, not recruiting

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Conditions: Deleterious BARD1 Gene Mutation; Deleterious BRCA1 Gene Mutation; Deleterious BRCA2 Gene Mutation; Deleterious BRIP1 Gene Mutation; Deleterious EPCAM Gene Mutation; Deleterious MLH1 Gene Mutation; Deleterious MSH2 Gene Mutation; Deleterious MSH6 Gene Mutation; Deleterious PALB2 Gene Mutation; Deleterious PMS2 Gene Mutation; Deleterious RAD51C Gene Mutation; Deleterious RAD51D Gene Mutation; Hereditary Breast and Ovarian Cancer Syndrome; Premenopausal
NCT02203513

Active, not recruiting

A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer

Conditions: Ovarian Cancer; Breast Cancer; Prostate Cancer